Opens in a new tab

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Published Scientific Evidence

Anumana’s ECG-AI® technology is supported by one of the most extensive evidence bases in cardiovascular AI. This library provides direct access to our peer-reviewed validation studies and broader body of clinical research.

November
12
2025
{post_date: F d, Y}
JACC

Predicting Heart Failure From 12-Lead ECGs Using AI: A HeartShare/AMP-HF Pooled Cohort Analysis

Abstract Background: Artificial intelligence applied to electrocardiograms (ECG-AI) offers a scalable approach to identify individuals at risk for heart failure (HF) and guide preventive interventions. Objective: The purpose of this study was…
August
25
2025
{post_date: F d, Y}
CJASN

Validation of Noninvasive Detection of Hyperkalemia by Artificial Intelligence-Enhanced Electrocardiography in High Acuity Settings

Abstract:  Key Points  • Measuring blood potassium has always required access to blood. The surface electrocardiogram, analyzed using an artificial intelligence algorithm, can detect hyperkalemia bloodlessly. • The artificial intelligence-analyzed…